Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Monday 1st July saw the official launch of OCTRU in its current form by an event hosted by the Co-Directors and Strategic Leads of the unit

Professors Hamdy, Altman, Dr Travis, Professors Lamb, Carr and Maughan (L to R) Dr Rahman is missing from this group

Today saw the launch to members of the Oncology Clinical Trials Office (OCTO), the Surgical Interventional Trials Unit (SITU), the Gastroenterology Trials Group, the Oxford Respiratory Trials Unit (ORTU) and the trials groups from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences of OCTRU in its new format.  OCTRU has brought together previously provisionally and fully registered trials unit to unite to form a centre of trials expertise and excellence in Oxford.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Three NIHR HTA grants awarded to Professor Tim Theologis

Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.